Intervention not reported
Overall pain · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall sexuality change ‐ 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall sleep disturbance · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Death within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in death within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Disease progression within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention probably leads to lower disease progression within 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Haematological adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in haematological adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Gastrointestinal adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in gastrointestinal adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Genitourinary adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in genitourinary adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall QoL change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall physical function change score ‐ 6 months' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall role function change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall role function · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall social function change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall social function · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall QoL · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall anxiety · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall anxiety · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall depression · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall depression · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall fatigue change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review